Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Melanie Joy

Concepts (391)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glomerulonephritis
8
2021
64
3.660
Why?
Cyclophosphamide
5
2021
234
2.540
Why?
Lupus Nephritis
5
2021
56
2.540
Why?
Cisplatin
8
2022
277
2.480
Why?
Kidney
15
2022
1191
2.470
Why?
Acute Kidney Injury
11
2022
600
2.240
Why?
Mycophenolic Acid
7
2016
81
2.120
Why?
Glomerulosclerosis, Focal Segmental
6
2015
41
2.090
Why?
Kidney Diseases
9
2016
402
1.970
Why?
Organic Anion Transporters
2
2021
27
1.560
Why?
Immunosuppressive Agents
5
2021
678
1.470
Why?
Pharmaceutical Preparations
4
2021
174
1.390
Why?
Kidney Failure, Chronic
13
2009
499
1.350
Why?
Autoimmune Diseases
4
2021
410
1.340
Why?
Membrane Transport Proteins
3
2017
152
1.290
Why?
Enzyme Inhibitors
4
2010
931
1.170
Why?
Vitamin D
3
2022
345
1.160
Why?
Antineoplastic Agents
6
2022
2032
1.150
Why?
Cholecalciferol
2
2022
49
1.140
Why?
Vasculitis
6
2012
85
1.100
Why?
Glucuronides
4
2015
21
1.050
Why?
Antibodies, Antineutrophil Cytoplasmic
5
2010
32
0.910
Why?
Aryl Hydrocarbon Hydroxylases
3
2012
51
0.900
Why?
Uremia
1
2021
19
0.880
Why?
Proteinuria
6
2017
104
0.870
Why?
Adalimumab
4
2015
41
0.860
Why?
Creatinine
11
2021
453
0.850
Why?
Renal Dialysis
11
2007
362
0.830
Why?
Glomerular Filtration Rate
6
2018
587
0.830
Why?
Rituximab
2
2018
167
0.820
Why?
Anti-Inflammatory Agents
3
2013
458
0.770
Why?
Calcineurin Inhibitors
3
2016
63
0.770
Why?
Glomerulonephritis, Membranous
1
2018
5
0.750
Why?
Membranes, Artificial
3
2018
75
0.750
Why?
Hemoperfusion
1
2018
5
0.730
Why?
Lanthanum
4
2006
12
0.720
Why?
Hyperphosphatemia
1
2018
16
0.720
Why?
Glucuronosyltransferase
3
2015
10
0.710
Why?
Kidney Tubules, Proximal
2
2016
93
0.690
Why?
Anemia
3
2009
163
0.680
Why?
Pharmacogenomic Variants
1
2017
33
0.670
Why?
Simvastatin
1
2017
68
0.660
Why?
Humans
74
2022
113890
0.660
Why?
Oleanolic Acid
1
2016
9
0.640
Why?
Terfenadine
2
2013
2
0.630
Why?
Hyperparathyroidism, Secondary
3
2007
14
0.630
Why?
Azathioprine
1
2016
53
0.610
Why?
Enzymes
1
2016
71
0.590
Why?
Adult
31
2021
31958
0.570
Why?
Pharmacogenetics
1
2016
152
0.560
Why?
Renal Insufficiency, Chronic
2
2013
493
0.560
Why?
Brain Diseases
1
2016
160
0.550
Why?
Middle Aged
29
2021
28776
0.540
Why?
Oxidoreductases, N-Demethylating
2
2012
11
0.540
Why?
Flurbiprofen
1
2013
4
0.530
Why?
Male
40
2022
60623
0.530
Why?
Liver Diseases
1
2016
273
0.520
Why?
Biomarkers
8
2022
3468
0.520
Why?
Metabolic Clearance Rate
7
2018
134
0.520
Why?
Pharmacokinetics
2
2012
32
0.510
Why?
Female
38
2021
62822
0.500
Why?
Hypothyroidism
1
2013
72
0.490
Why?
Leukocytes
1
2014
292
0.480
Why?
Multidrug Resistance-Associated Proteins
3
2017
38
0.480
Why?
Half-Life
5
2018
171
0.470
Why?
Serum Albumin
5
2012
159
0.470
Why?
Metabolic Networks and Pathways
1
2013
175
0.470
Why?
Cytochrome P-450 Enzyme System
2
2016
129
0.460
Why?
Antibodies, Monoclonal, Humanized
3
2013
647
0.460
Why?
Heptanoic Acids
3
2011
69
0.440
Why?
Patient Care Team
2
2007
533
0.440
Why?
Losartan
2
2011
14
0.420
Why?
Naphthalenes
3
2007
59
0.420
Why?
Tacrolimus
2
2016
146
0.410
Why?
Nephrology
2
2007
31
0.410
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2010
15
0.410
Why?
Aged
18
2018
20127
0.400
Why?
Bupropion
1
2010
38
0.400
Why?
RNA, Messenger
3
2016
2817
0.400
Why?
Pyrroles
3
2011
202
0.400
Why?
Phosphates
2
2018
175
0.400
Why?
Organic Cation Transporter 2
2
2021
12
0.400
Why?
Epithelial Cells
1
2016
1018
0.400
Why?
Antidepressive Agents, Second-Generation
1
2010
43
0.400
Why?
Anticholesteremic Agents
3
2011
136
0.390
Why?
Kidney Transplantation
3
2009
518
0.390
Why?
Organic Cation Transport Proteins
2
2021
36
0.390
Why?
Dose-Response Relationship, Drug
8
2016
2185
0.360
Why?
Hypercholesterolemia
2
2007
102
0.340
Why?
Thiazolidinediones
1
2008
158
0.340
Why?
Milrinone
2
2018
30
0.330
Why?
Polymorphism, Single Nucleotide
3
2017
1741
0.330
Why?
Severity of Illness Index
2
2013
2845
0.330
Why?
Lipoproteins
1
2007
171
0.320
Why?
Neoplasms
3
2018
2060
0.320
Why?
Antibodies, Monoclonal
2
2011
1288
0.310
Why?
Pharmacists
2
2007
251
0.310
Why?
Biological Transport
4
2021
427
0.310
Why?
Erythropoietin
2
2007
84
0.310
Why?
Ambulatory Care
2
2007
459
0.300
Why?
Area Under Curve
4
2018
322
0.300
Why?
Vitamins
1
2007
148
0.300
Why?
Granulomatosis with Polyangiitis
1
2005
37
0.300
Why?
Glycated Hemoglobin A
2
2002
781
0.290
Why?
Prodrugs
1
2005
42
0.290
Why?
Antihypertensive Agents
1
2009
458
0.290
Why?
NF-E2-Related Factor 2
2
2016
80
0.290
Why?
Case Management
1
2005
69
0.280
Why?
Chronic Disease
7
2012
1652
0.280
Why?
Organ Transplantation
1
2007
157
0.280
Why?
Cyclosporine
1
2005
181
0.280
Why?
Aniline Compounds
1
2004
63
0.280
Why?
Hemofiltration
3
2000
32
0.270
Why?
Regression Analysis
3
2018
1110
0.270
Why?
Quality Assurance, Health Care
1
2007
377
0.270
Why?
Treatment Outcome
10
2013
9100
0.260
Why?
HEK293 Cells
4
2021
647
0.250
Why?
Vitamin D3 24-Hydroxylase
1
2022
14
0.240
Why?
Chromatography, Liquid
3
2021
340
0.240
Why?
Carcinoma, Renal Cell
2
2015
170
0.230
Why?
Blood Pressure
1
2009
1728
0.230
Why?
Cytochrome P-450 CYP2C9
2
2013
16
0.230
Why?
Cytochrome P-450 CYP2B6
2
2012
11
0.230
Why?
Genotype
3
2014
1851
0.220
Why?
Imatinib Mesylate
1
2021
65
0.220
Why?
Vancomycin
2
2021
60
0.220
Why?
Biomedical Research
1
2007
585
0.220
Why?
Antiemetics
1
2021
35
0.220
Why?
Young Adult
7
2021
10971
0.220
Why?
Tissue Distribution
2
2013
362
0.220
Why?
Particle Size
2
2021
384
0.210
Why?
Models, Biological
2
2021
1812
0.210
Why?
Cytochrome P-450 CYP3A
2
2013
59
0.210
Why?
Kidney Neoplasms
2
2015
326
0.200
Why?
Exosomes
1
2021
79
0.200
Why?
Administration, Oral
4
2018
795
0.200
Why?
Mitogen-Activated Protein Kinase Kinases
1
2020
125
0.200
Why?
Polymorphism, Genetic
2
2016
661
0.200
Why?
Pilot Projects
4
2018
1412
0.190
Why?
Age Factors
3
2015
3271
0.190
Why?
Tricarboxylic Acids
1
2018
12
0.180
Why?
Off-Label Use
1
2018
44
0.180
Why?
Hematinics
2
2009
21
0.180
Why?
Follow-Up Studies
6
2011
4927
0.180
Why?
Animals
11
2022
34695
0.180
Why?
Clonazepam
1
1997
7
0.180
Why?
Kidney Function Tests
3
2017
159
0.180
Why?
GABA Modulators
1
1997
13
0.180
Why?
Indican
1
2017
1
0.180
Why?
Prospective Studies
5
2018
6292
0.170
Why?
Renal Replacement Therapy
1
1998
63
0.170
Why?
Quality of Life
1
2009
2197
0.170
Why?
Glutathione S-Transferase pi
1
2017
9
0.170
Why?
Adsorption
1
2018
154
0.170
Why?
Anti-Anxiety Agents
1
1997
51
0.170
Why?
Restless Legs Syndrome
1
1997
24
0.170
Why?
Thyroid Diseases
2
2007
38
0.170
Why?
Infusions, Intravenous
1
2018
405
0.170
Why?
Parathyroid Hormone
4
2007
117
0.170
Why?
Osteoporosis
1
2000
195
0.170
Why?
Child
8
2016
17710
0.170
Why?
Xenobiotics
1
2017
26
0.160
Why?
Fructose
1
2018
193
0.160
Why?
Adolescent
9
2015
18580
0.160
Why?
Phosphorus
3
2006
95
0.160
Why?
Cation Transport Proteins
1
2017
116
0.160
Why?
Subcutaneous Absorption
1
2015
1
0.150
Why?
Hemoglobins
2
2009
284
0.150
Why?
Adrenal Cortex Hormones
1
2000
508
0.150
Why?
Gene Expression Regulation
2
2016
2564
0.150
Why?
Tumor Necrosis Factor-alpha
2
2013
1241
0.150
Why?
Drug Interactions
1
2017
405
0.150
Why?
Hydroxychloroquine
1
2016
58
0.150
Why?
Injections, Subcutaneous
1
2015
159
0.150
Why?
Cell Survival
2
2016
1138
0.150
Why?
Phthalimides
1
2015
1
0.150
Why?
Darbepoetin alfa
2
2007
5
0.150
Why?
Blood-Brain Barrier
1
2016
114
0.150
Why?
Societies, Pharmaceutical
2
2005
28
0.150
Why?
Proteomics
1
2021
756
0.150
Why?
Isoquinolines
1
2015
42
0.140
Why?
Hepatocytes
1
2016
206
0.140
Why?
Blood Glucose
2
2018
1873
0.140
Why?
Drug Therapy
1
1995
83
0.140
Why?
Reactive Oxygen Species
1
2017
548
0.140
Why?
Cholesterol, LDL
2
2007
309
0.140
Why?
RNA Isoforms
1
2013
2
0.140
Why?
C-Reactive Protein
2
2007
347
0.140
Why?
Tenofovir
1
2016
220
0.130
Why?
Tandem Mass Spectrometry
2
2021
386
0.130
Why?
Case-Control Studies
3
2013
3247
0.130
Why?
Breath Tests
1
2013
92
0.130
Why?
Protein Kinase Inhibitors
1
2020
852
0.130
Why?
Critical Care
1
1998
511
0.130
Why?
Angiotensin II Type 1 Receptor Blockers
2
2011
38
0.120
Why?
Myocytes, Cardiac
1
2017
495
0.120
Why?
Complement Activation
1
2015
336
0.120
Why?
Liver
2
2018
1825
0.120
Why?
Treatment Failure
1
2013
334
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2015
403
0.120
Why?
Cells, Cultured
2
2021
4287
0.120
Why?
Alternative Splicing
1
2013
210
0.110
Why?
Drug Resistance
2
2011
186
0.110
Why?
Galactose
1
2011
23
0.110
Why?
Disease Models, Animal
1
2021
3850
0.110
Why?
Mice
3
2022
15400
0.110
Why?
Critical Illness
1
2016
579
0.100
Why?
Cephalosporins
2
2000
24
0.100
Why?
Drug Administration Schedule
2
2003
806
0.100
Why?
Stereoisomerism
1
2010
112
0.100
Why?
Lupus Erythematosus, Systemic
1
2012
255
0.100
Why?
Inflammation
1
2021
2431
0.100
Why?
Randomized Controlled Trials as Topic
3
2004
1154
0.100
Why?
Fetus
1
2013
655
0.100
Why?
Diabetes Mellitus
1
1998
952
0.100
Why?
Anti-Allergic Agents
1
2009
51
0.100
Why?
Calcium
4
2005
1195
0.090
Why?
Lipocalin-2
2
2020
56
0.090
Why?
Body Surface Area
1
2008
30
0.090
Why?
Quality Indicators, Health Care
1
2012
314
0.090
Why?
Mass Spectrometry
1
2012
703
0.090
Why?
Anti-Bacterial Agents
1
1998
1365
0.090
Why?
Diabetes Mellitus, Type 2
1
2002
1944
0.090
Why?
Patient Safety
1
2012
303
0.090
Why?
Promoter Regions, Genetic
1
2013
1230
0.090
Why?
Cholesterol
2
2007
374
0.090
Why?
Chromatography, High Pressure Liquid
1
2010
545
0.090
Why?
Gene Frequency
1
2009
429
0.090
Why?
Hepatitis A Virus Cellular Receptor 1
2
2018
39
0.090
Why?
Antithyroid Agents
1
2007
10
0.090
Why?
Steroids
1
2008
133
0.090
Why?
Gene Expression
3
2021
1529
0.090
Why?
Statistics, Nonparametric
1
2009
459
0.090
Why?
Apolipoprotein A-I
1
2007
26
0.090
Why?
Apolipoproteins B
1
2007
56
0.090
Why?
Parathyroidectomy
1
2007
6
0.090
Why?
Renal Insufficiency
1
2009
125
0.090
Why?
Canada
1
2008
321
0.090
Why?
Ergocalciferols
1
2007
14
0.090
Why?
Lipoprotein(a)
1
2007
44
0.090
Why?
Kidney Tubules, Distal
1
2007
2
0.090
Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2007
13
0.080
Why?
Ferrous Compounds
1
2007
26
0.080
Why?
Pharmacy
1
2007
33
0.080
Why?
Linear Models
1
2010
884
0.080
Why?
Aged, 80 and over
3
2017
6818
0.080
Why?
Calcitriol
1
2007
52
0.080
Why?
Fibrinogen
1
2007
158
0.080
Why?
Polysaccharides
1
2007
80
0.080
Why?
Child, Preschool
3
2011
9618
0.080
Why?
History, 21st Century
1
2007
198
0.080
Why?
Staining and Labeling
1
2007
168
0.080
Why?
Drug Costs
1
2007
96
0.080
Why?
Health Knowledge, Attitudes, Practice
1
1995
1242
0.080
Why?
History, 20th Century
1
2007
309
0.080
Why?
Phosphorus Metabolism Disorders
1
2005
2
0.070
Why?
Social Behavior
1
2009
331
0.070
Why?
Diabetes Mellitus, Type 1
1
2002
3136
0.070
Why?
Role
1
2005
33
0.070
Why?
Professional Role
1
2007
162
0.070
Why?
Hypertension
2
2005
1184
0.070
Why?
Iron
1
2007
230
0.070
Why?
Coloring Agents
1
2005
78
0.070
Why?
Propylamines
1
2004
15
0.070
Why?
Phenethylamines
1
2004
24
0.070
Why?
Bone Diseases, Metabolic
1
2005
59
0.070
Why?
Program Development
1
2007
367
0.070
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2011
227
0.070
Why?
Safety
2
2004
327
0.070
Why?
Cost-Benefit Analysis
1
2007
553
0.070
Why?
Hyperlipidemias
1
2005
141
0.070
Why?
Phenotype
2
2010
2842
0.070
Why?
Hyperparathyroidism
1
2003
10
0.070
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2003
17
0.070
Why?
Interdisciplinary Communication
1
2005
204
0.070
Why?
Time Factors
3
2008
7011
0.060
Why?
Brain
1
2016
2711
0.060
Why?
Nausea
1
2003
118
0.060
Why?
Comorbidity
2
2005
1631
0.060
Why?
Diabetes Complications
1
2005
234
0.060
Why?
Guidelines as Topic
1
2005
288
0.060
Why?
Cell Membrane
1
2007
755
0.060
Why?
Feasibility Studies
1
2005
747
0.060
Why?
Calbindins
1
2022
4
0.060
Why?
Recurrence
1
2005
975
0.060
Why?
Sex Factors
1
2009
1961
0.060
Why?
Immunohistochemistry
1
2007
1763
0.060
Why?
Double-Blind Method
2
2004
1670
0.060
Why?
Rats
2
2018
6203
0.060
Why?
Sleep
1
2009
727
0.060
Why?
Drug Eruptions
1
2002
26
0.060
Why?
Serotonin 5-HT3 Receptor Antagonists
1
2021
1
0.060
Why?
Madin Darby Canine Kidney Cells
1
2021
15
0.060
Why?
United States
2
2008
12446
0.060
Why?
Cell Line
2
2021
2930
0.060
Why?
Retrospective Studies
1
2017
11544
0.050
Why?
Signal Transduction
1
2015
4887
0.050
Why?
Clinical Trials as Topic
1
2006
1005
0.050
Why?
Mice, Inbred C57BL
2
2022
5143
0.050
Why?
Ceftazidime
1
2000
6
0.050
Why?
Ceftriaxone
1
2000
20
0.050
Why?
Blood Urea Nitrogen
1
2020
61
0.050
Why?
Butadienes
1
2020
36
0.050
Why?
Disease Progression
2
2005
2476
0.050
Why?
Dogs
1
2021
432
0.050
Why?
Calcium, Dietary
1
2000
50
0.050
Why?
Molecular Structure
1
2021
495
0.050
Why?
Pyrimidinones
1
2020
95
0.050
Why?
Logistic Models
1
2005
2051
0.050
Why?
Quality of Health Care
1
2005
647
0.050
Why?
Nitriles
1
2020
163
0.050
Why?
Pyridones
1
2020
113
0.050
Why?
Absorptiometry, Photon
1
2000
242
0.050
Why?
Tumor Burden
1
2020
287
0.050
Why?
Acrylonitrile
1
1998
3
0.050
Why?
Biological Availability
1
2018
146
0.050
Why?
Cohort Studies
1
2009
4993
0.050
Why?
Tissue Inhibitor of Metalloproteinase-2
1
2018
11
0.050
Why?
Polymethyl Methacrylate
1
1998
22
0.050
Why?
Insulin-Like Growth Factor Binding Proteins
1
2018
22
0.050
Why?
Prevalence
1
2005
2392
0.050
Why?
Incidence
1
2005
2449
0.050
Why?
Acrylic Resins
1
1998
39
0.040
Why?
Urea
1
1998
86
0.040
Why?
MAP Kinase Signaling System
1
2020
317
0.040
Why?
Sulfones
1
1998
104
0.040
Why?
Rats, Wistar
1
2018
414
0.040
Why?
Cardiotonic Agents
1
2018
140
0.040
Why?
Thoracic Surgery
1
2018
123
0.040
Why?
ROC Curve
1
2018
494
0.040
Why?
Drug Monitoring
1
1998
190
0.040
Why?
Surveys and Questionnaires
1
2009
4711
0.040
Why?
Diabetic Nephropathies
1
2000
276
0.040
Why?
Neoplasm Proteins
1
2020
433
0.040
Why?
Bone Density
1
2000
403
0.040
Why?
Complement C5b
1
2015
4
0.040
Why?
Cardiovascular Diseases
1
2007
1670
0.040
Why?
Pennsylvania
1
1995
115
0.040
Why?
Sulfoxides
1
2015
6
0.040
Why?
Kelch-Like ECH-Associated Protein 1
1
2015
7
0.040
Why?
Isothiocyanates
1
2015
6
0.040
Why?
Risk Factors
3
2012
9036
0.040
Why?
Protein Transport
1
2017
446
0.040
Why?
Acute Disease
1
1998
989
0.040
Why?
Active Transport, Cell Nucleus
1
2015
129
0.030
Why?
Mental Recall
1
1995
204
0.030
Why?
Hep G2 Cells
1
2013
77
0.030
Why?
Polymers
1
1998
479
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
351
0.030
Why?
Intestinal Mucosa
1
2018
518
0.030
Why?
Vasodilator Agents
1
2016
336
0.030
Why?
Glucose
1
2018
893
0.030
Why?
Organ Specificity
1
2013
299
0.030
Why?
Exons
1
2013
306
0.030
Why?
Carrier Proteins
1
2017
814
0.030
Why?
Cell Proliferation
1
2020
2362
0.030
Why?
Genetic Variation
1
2017
824
0.030
Why?
Infant
2
2018
8065
0.030
Why?
Cell Nucleus
1
2015
615
0.030
Why?
Insulin
1
2002
2132
0.030
Why?
Medication Errors
1
2012
97
0.030
Why?
Lisinopril
1
2011
20
0.030
Why?
Patient Compliance
1
1995
605
0.030
Why?
Diagnostic Errors
1
2012
158
0.030
Why?
Terminology as Topic
1
2012
206
0.030
Why?
Practice Guidelines as Topic
2
2012
1525
0.030
Why?
Limit of Detection
1
2009
53
0.030
Why?
Patient Education as Topic
1
1995
738
0.030
Why?
Liver Neoplasms
1
2013
457
0.020
Why?
Apoptosis
1
2020
2609
0.020
Why?
Calibration
1
2009
139
0.020
Why?
Quality Control
1
2009
166
0.020
Why?
Reference Standards
1
2009
193
0.020
Why?
Drug Stability
1
2009
233
0.020
Why?
Drug Therapy, Combination
1
2011
1011
0.020
Why?
Guideline Adherence
1
2012
540
0.020
Why?
Infant, Newborn
1
2018
5014
0.020
Why?
Lung Neoplasms
1
2020
2169
0.020
Why?
Predictive Value of Tests
1
2012
1997
0.020
Why?
Mutation
1
2017
3403
0.020
Why?
Expert Testimony
1
2005
54
0.020
Why?
Clinical Competence
1
2012
917
0.020
Why?
Drug Tolerance
1
2004
150
0.020
Why?
Algorithms
1
2011
1514
0.020
Why?
Receptors, Calcium-Sensing
1
2003
7
0.020
Why?
Hypercalcemia
1
2003
23
0.020
Why?
Triglycerides
1
2005
534
0.010
Why?
Risk Assessment
1
2012
3177
0.010
Why?
Receptors, Cell Surface
1
2003
395
0.010
Why?
Injections, Intravenous
1
2000
242
0.010
Why?
Albuminuria
1
2000
181
0.010
Why?
Joy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)